Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


L&S Research

This article was originally published in The Tan Sheet

Executive Summary

Discontinues advertising for its Cybergenics Cybertrim and Cybergenics Quick Trim products, according to a case report from the National Advertising Division of the Council for Better Business Bureaus. After NAD requested substantiation for weight loss claims and product endorsements made for the Cybergenics products, L&S Research said it discontinued the ads in question and is "undertaking a complete review of all of its advertising, promotional materials and labeling" and will be revising those materials. The company recently received a warning letter from FDA that cited some Cybergenics products as unapproved new drugs based on weight control claims ("The Tan Sheet" Feb. 21, In Brief)

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts